Aspira Pathlab & Diagnostics Ltd — Updates, 10-07-2025: Company Update

Aspira Pathlab & Diagnostics Limited has announced a board meeting to approve the re-appointment and remuneration of Dr. Pankaj Shah as Managing Director & CEO for a three-year term from August 2025 to July 2028. Dr. Shah brings over 43 years of pathology experience and has been a key figure in the company’s growth. He is not related to any other director or key managerial personnel and is free from any regulatory restrictions. This continuity in leadership supports the company’s strategic direction and operational stability.